Atomi Financial Group Inc. Acquires 974 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Atomi Financial Group Inc. lifted its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 71.5% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,337 shares of the medical equipment provider’s stock after buying an additional 974 shares during the period. Atomi Financial Group Inc.’s holdings in Intuitive Surgical were worth $1,220,000 at the end of the most recent reporting period.

Other large investors also recently bought and sold shares of the company. Godsey & Gibb Inc. raised its stake in Intuitive Surgical by 140.0% during the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock valued at $29,000 after buying an additional 35 shares during the last quarter. MidAtlantic Capital Management Inc. bought a new stake in shares of Intuitive Surgical in the third quarter worth $33,000. Decker Retirement Planning Inc. purchased a new stake in Intuitive Surgical during the fourth quarter valued at $36,000. Capital Performance Advisors LLP bought a new position in Intuitive Surgical in the third quarter valued at about $38,000. Finally, DT Investment Partners LLC boosted its position in Intuitive Surgical by 80.0% in the third quarter. DT Investment Partners LLC now owns 81 shares of the medical equipment provider’s stock worth $40,000 after purchasing an additional 36 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors.

Insider Transactions at Intuitive Surgical

In other news, CEO Gary S. Guthart sold 18,151 shares of Intuitive Surgical stock in a transaction that occurred on Wednesday, October 30th. The stock was sold at an average price of $511.63, for a total value of $9,286,596.13. Following the completion of the transaction, the chief executive officer now owns 24,219 shares in the company, valued at approximately $12,391,166.97. The trade was a 42.84 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Jamie Samath sold 270 shares of the stock in a transaction on Tuesday, December 10th. The shares were sold at an average price of $540.15, for a total value of $145,840.50. Following the sale, the chief financial officer now owns 8,757 shares in the company, valued at $4,730,093.55. The trade was a 2.99 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 43,509 shares of company stock worth $22,602,212 in the last three months. Insiders own 0.80% of the company’s stock.

Intuitive Surgical Stock Up 1.9 %

Intuitive Surgical stock opened at $604.12 on Wednesday. Intuitive Surgical, Inc. has a 52-week low of $362.14 and a 52-week high of $606.27. The firm’s fifty day moving average is $541.80 and its 200 day moving average is $500.76. The company has a market cap of $215.18 billion, a price-to-earnings ratio of 97.13, a PEG ratio of 5.04 and a beta of 1.39.

Wall Street Analysts Forecast Growth

A number of research firms recently issued reports on ISRG. Morgan Stanley raised shares of Intuitive Surgical from an “equal weight” rating to an “overweight” rating and raised their price objective for the stock from $522.00 to $650.00 in a report on Monday, December 2nd. Raymond James lifted their price target on shares of Intuitive Surgical from $500.00 to $540.00 and gave the stock an “outperform” rating in a research note on Monday, October 14th. JPMorgan Chase & Co. raised their target price on Intuitive Surgical from $495.00 to $575.00 and gave the stock an “overweight” rating in a report on Friday, October 11th. Robert W. Baird boosted their price target on Intuitive Surgical from $503.00 to $565.00 and gave the company an “outperform” rating in a report on Thursday, October 17th. Finally, Royal Bank of Canada raised their price objective on Intuitive Surgical from $525.00 to $555.00 and gave the stock an “outperform” rating in a research note on Friday, October 18th. One investment analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have issued a buy rating to the company’s stock. According to MarketBeat, Intuitive Surgical currently has an average rating of “Moderate Buy” and a consensus target price of $554.17.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.